Warning: The NCBI web site requires JavaScript to function. more...
Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.
Goila-Gaur R, Khan MA, Miyagi E, Kao S, Strebel K.
Retrovirology. 2007 Aug 29;4:61.
Related citations
Vpr.A3A chimera inhibits HIV replication.
Aguiar RS, Lovsin N, Tanuri A, Peterlin BM.
J Biol Chem. 2008 Feb 1;283(5):2518-25. Epub 2007 Dec 5.
Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.
Ao Z, Yu Z, Wang L, Zheng Y, Yao X.
PLoS One. 2008 Apr 16;3(4):e1995.
Functional domain organization of human APOBEC3G.
Gooch BD, Cullen BR.
Virology. 2008 Sep 15;379(1):118-24. Epub 2008 Jul 18.
Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA, Pathak VK.
J Virol. 2007 Aug;81(15):8201-10. Epub 2007 May 23.
Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z, Zhang W, Chen G, Xu R, Yu XF.
J Mol Biol. 2008 Sep 12;381(4):1000-11. Epub 2008 Jun 28.
Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.
Dang Y, Wang X, Zhou T, York IA, Zheng YH.
J Virol. 2009 Sep;83(17):8544-52. Epub 2009 Jun 17.
Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
Tian C, Yu X, Zhang W, Wang T, Xu R, Yu XF.
J Virol. 2006 Mar;80(6):3112-5.
Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
Narvaiza I, Linfesty DC, Greener BN, Hakata Y, Pintel DJ, Logue E, Landau NR, Weitzman MD.
PLoS Pathog. 2009 May;5(5):e1000439. Epub 2009 May 22.
Ubiquitin-fusion as a strategy to modulate protein half-life: A3G antiviral activity revisited.
Cadima-Couto I, Freitas-Vieira A, Nowarski R, Britan-Rosich E, Kotler M, Goncalves J.
Virology. 2009 Oct 25;393(2):286-94. Epub 2009 Aug 29.
A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H, Svarovskaia ES, Barr R, Zhang Y, Khan MA, Strebel K, Pathak VK.
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5652-7. Epub 2004 Mar 30.
Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism.
Marin M, Golem S, Rose KM, Kozak SL, Kabat D.
J Virol. 2008 Jan;82(2):987-98. Epub 2007 Oct 31.
Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.
Shirakawa K, Takaori-Kondo A, Yokoyama M, Izumi T, Matsui M, Io K, Sato T, Sato H, Uchiyama T.
Nat Struct Mol Biol. 2008 Nov;15(11):1184-91. Epub 2008 Oct 5.
Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G.
Rose KM, Marin M, Kozak SL, Kabat D.
AIDS Res Hum Retroviruses. 2005 Jul;21(7):611-9.
RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.
Bernacchi S, Henriet S, Dumas P, Paillart JC, Marquet R.
J Biol Chem. 2007 Sep 7;282(36):26361-8. Epub 2007 Jul 2.
Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
Liu B, Sarkis PT, Luo K, Yu Y, Yu XF.
J Virol. 2005 Aug;79(15):9579-87.
Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
Dang Y, Wang X, York IA, Zheng YH.
J Virol. 2010 Sep;84(17):8561-70. Epub 2010 Jun 30.
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration.
Mbisa JL, Barr R, Thomas JA, Vandegraaff N, Dorweiler IJ, Svarovskaia ES, Brown WL, Mansky LM, Gorelick RJ, Harris RS, Engelman A, Pathak VK.
J Virol. 2007 Jul;81(13):7099-110. Epub 2007 Apr 11.
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
Casartelli N, Guivel-Benhassine F, Bouziat R, Brandler S, Schwartz O, Moris A.
J Exp Med. 2010 Jan 18;207(1):39-49. Epub 2009 Dec 28.
APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
Han Y, Wang X, Dang Y, Zheng YH.
PLoS Pathog. 2008 Jul 4;4(7):e1000095.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on